logo

Otonomy Inc. (OTIC)



Trade OTIC now with
  Date
  Headline
7/9/2020 9:13:43 AM Otonomy Prices Public Offering Of 14.50 Mln Shares At $3.25 Per Share
5/7/2020 7:50:58 AM Otonomy Q1 Loss/Shr $0.38 Vs Loss $0.39 Last Year
4/9/2020 7:39:47 AM Otonomy Provides Business Update Related To COVID-19; Still Sees FY Non-GAAP Operating Expenses Of $35-$38 Mln
1/28/2020 7:35:58 AM Otonomy Presents Preclinical Results For GJB2 Gene Therapy Collaboration And Cisplatin Otoprotection Program
10/1/2019 7:39:20 AM Applied Genetic Technologies, Otonomy Enter Strategic Collaboration
9/17/2019 7:34:21 AM Otonomy Begins Phase 1/2 Clinical Trial Of OTO-413
4/11/2019 7:35:27 AM Otonomy Initiates Phase 1/2 Clinical Trial Of OTO-313 In Tinnitus
3/4/2019 4:49:15 PM Otonomy Q4 Loss Narrows
3/4/2019 4:28:27 PM Otonomy Q4 Loss/share $0.42 Vs. Loss $0.62 Year Ago
10/2/2018 7:32:47 AM Otonomy Announces OTIVIDEX Data Presentation At AAO-HNSF
7/26/2018 7:39:00 AM Otonomy Initiates Phase 3 Clinical Trial Of OTIVIDEX In Ménière’s Disease